Biomarker IP after Prometheus: Patenting the Unpatentable

3,670 views

|

November 18, 2013

In this tag-team presentation, two IP lawyers will discuss the latest trends in this evolving field: The Supreme Court decision in Mayo Collaborative Services v. Prometheus Laboratories, Inc. shifted the biomarker IP landscape by raising the bar to obtain meaningful patent protection for diagnostic methods involving biomarker detection. We will review recent developments in patent law concerning diagnostic method claims, and the approaches we are currently using to successfully address the Prometheus standard.

DiagnosticsMass SpectrometryPersonalized Medicine

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.